• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

当在受精周期中对 FSH 剂量进行个体化时,两种抗苗勒管激素检测方法的可互换性。

The interchangeability of two assays for the measurement of anti-Müllerian hormone when personalizing the dose of FSH in fertilization cycles.

机构信息

Department of Medical and Surgical Sciences for Mother, Child and Adult, University of Modena and Reggio Emilia, Modena, Italy.

Mamata Fertility Hospital, Secunderabad, India.

出版信息

Gynecol Endocrinol. 2021 Apr;37(4):372-376. doi: 10.1080/09513590.2020.1810659. Epub 2020 Aug 28.

DOI:10.1080/09513590.2020.1810659
PMID:32856971
Abstract

OBJECTIVE

Study the interchangeability of Roche Elecsys and Beckman Coulter Access anti-Müllerian Hormone (AMH) assays to select the gonadotropin starting dose in IVF cycles.

METHODS

Patients' AMH was measured using both Elecsys and Access automated assays. AMH values were then used to calculate the FSH starting dose. The main outcome is the percentage of women that would have been stratified to a different dose of gonadotropin due to differences in AMH values from the two tests.

RESULTS

The Access assay systematically gives higher values compared with the Elecsys assay (slope = 0.88). For Follitropin Alfa, the difference in starting dose was > 15% in 2/113 patients, when Access AMH was used instead of Elecsys. For Follitropin Delta the difference in the starting dose was >15% in 21/113 patients when using Access AMH. When considering women with high ovarian reserve, only 4/51 would have received a Follitropin Delta dose that exceeded a 15% difference using Access AMH as a substitute for the Elecsys value.

CONCLUSIONS

The use of the Roche Elecsys or Beckman Coulter Access leads to modest differences in AMH values, which seem to little affect the calibration of FSH dose used for ovarian stimulation.

摘要

目的

研究罗氏 Elecsys 和贝克曼库尔特 Access 抗缪勒管激素(AMH)检测试剂的互换性,以选择 IVF 周期中的促性腺激素起始剂量。

方法

使用 Elecsys 和 Access 自动检测试剂测量患者的 AMH。然后,使用 AMH 值计算 FSH 起始剂量。主要结局是由于两种检测方法的 AMH 值差异,会导致多少女性被分层到不同的促性腺激素剂量。

结果

与 Elecsys 检测试剂相比,Access 检测试剂系统地给出了更高的值(斜率=0.88)。对于 Follitropin Alfa,当使用 Access AMH 代替 Elecsys 时,有 2/113 名患者的起始剂量差异>15%。对于 Follitropin Delta,有 21/113 名患者的起始剂量差异>15%,当使用 Access AMH 时。当考虑卵巢储备功能高的女性时,只有 4/51 名患者使用 Access AMH 替代 Elecsys 值时,会接受超过 15%差异的 Follitropin Delta 剂量。

结论

罗氏 Elecsys 或贝克曼库尔特 Access 的使用导致 AMH 值略有差异,这似乎对用于卵巢刺激的 FSH 剂量的校准影响不大。

相似文献

1
The interchangeability of two assays for the measurement of anti-Müllerian hormone when personalizing the dose of FSH in fertilization cycles.当在受精周期中对 FSH 剂量进行个体化时,两种抗苗勒管激素检测方法的可互换性。
Gynecol Endocrinol. 2021 Apr;37(4):372-376. doi: 10.1080/09513590.2020.1810659. Epub 2020 Aug 28.
2
Non-equivalence of anti-Müllerian hormone automated assays-clinical implications for use as a companion diagnostic for individualised gonadotrophin dosing.抗苗勒氏管激素自动检测的不等效性——作为个体化促性腺激素剂量使用的伴随诊断的临床意义。
Hum Reprod. 2017 Aug 1;32(8):1710-1715. doi: 10.1093/humrep/dex219.
3
Individualized versus conventional ovarian stimulation for in vitro fertilization: a multicenter, randomized, controlled, assessor-blinded, phase 3 noninferiority trial.个体化与传统卵巢刺激用于体外受精:一项多中心、随机、对照、评估者盲法的3期非劣效性试验。
Fertil Steril. 2017 Feb;107(2):387-396.e4. doi: 10.1016/j.fertnstert.2016.10.033. Epub 2016 Nov 29.
4
Clinical application of a nomogram based on age, serum FSH and AMH to select the FSH starting dose in IVF/ICSI cycles: a retrospective two-centres study.基于年龄、血清卵泡刺激素(FSH)和抗缪勒管激素(AMH)的列线图在体外受精/卵胞浆内单精子注射(IVF/ICSI)周期中选择FSH起始剂量的临床应用:一项回顾性双中心研究
Eur J Obstet Gynecol Reprod Biol. 2016 Dec;207:94-99. doi: 10.1016/j.ejogrb.2016.10.021. Epub 2016 Oct 26.
5
Randomized, assessor-blind, antimüllerian hormone-stratified, dose-response trial in Japanese in vitro fertilization/intracytoplasmic sperm injection patients undergoing controlled ovarian stimulation with follitropin delta.随机、评估者盲、抗缪勒管激素分层、剂量反应试验在接受卵泡刺激素 δ 控制性卵巢刺激的日本体外受精/胞浆内精子注射患者中进行。
Fertil Steril. 2021 Jun;115(6):1478-1486. doi: 10.1016/j.fertnstert.2020.10.059. Epub 2020 Dec 4.
6
The addition of anti-Müllerian hormone in an algorithm for individualized hormone dosage did not improve the prediction of ovarian response-a randomized, controlled trial.抗苗勒管激素在个体化激素剂量算法中的添加并未改善卵巢反应的预测-一项随机对照试验。
Hum Reprod. 2017 Apr 1;32(4):811-819. doi: 10.1093/humrep/dex012.
7
Anti-Müllerian hormone versus antral follicle count for defining the starting dose of FSH.抗苗勒管激素与窦卵泡计数用于定义 FSH 的起始剂量。
Reprod Biomed Online. 2013 Oct;27(4):390-9. doi: 10.1016/j.rbmo.2013.07.008. Epub 2013 Jul 23.
8
Individualized FSH dosing based on ovarian reserve testing in women starting IVF/ICSI: a multicentre trial and cost-effectiveness analysis.基于卵巢储备测试的个体化 FSH 剂量在 IVF/ICSI 起始女性中的应用:一项多中心试验和成本效益分析。
Hum Reprod. 2017 Dec 1;32(12):2485-2495. doi: 10.1093/humrep/dex321.
9
Clinical outcomes of potential high responders after individualized FSH dosing based on anti-Müllerian hormone and body weight.基于抗苗勒管激素和体重的个体化促卵泡激素剂量设定后,潜在高反应者的临床结局。
Reprod Biomed Online. 2021 Dec;43(6):1019-1026. doi: 10.1016/j.rbmo.2021.08.024. Epub 2021 Sep 3.
10
The performance of the Elecsys® anti-Müllerian hormone assay in predicting extremes of ovarian response to corifollitropin alfa.Elecsys® 抗苗勒管激素测定在预测卵巢对重组促卵泡素α反应的极端情况中的表现。
Reprod Biomed Online. 2020 Jul;41(1):29-36. doi: 10.1016/j.rbmo.2020.03.023. Epub 2020 Apr 30.

引用本文的文献

1
Reduced reproductive potential in young healthy women with hereditary breast and/or ovarian cancer syndrome.患有遗传性乳腺癌和/或卵巢癌综合征的年轻健康女性生殖潜力降低。
Commun Med (Lond). 2025 Mar 8;5(1):70. doi: 10.1038/s43856-025-00788-9.
2
The pregnancy outcomes among women receiving individualized algorithm dosing with follitropin delta: a systematic review of randomized controlled trials.接受个体化算法剂量的 follitropin delta 的女性的妊娠结局:随机对照试验的系统评价。
J Assist Reprod Genet. 2024 Jul;41(7):1851-1861. doi: 10.1007/s10815-024-03146-1. Epub 2024 May 29.
3
Inadvertent Administration of 72 µg of Follitropin-Δ for Three Consecutive Days Does Not Appear to Be Dangerous for Poor Responders: A Case Series.
连续三天意外给予72微克促卵泡素-Δ对低反应者似乎并无危险:病例系列报道
J Clin Med. 2023 Aug 10;12(16):5202. doi: 10.3390/jcm12165202.
4
Anti-Müllerian hormone for the diagnosis and prediction of menopause: a systematic review.抗缪勒管激素用于绝经诊断和预测的系统评价。
Hum Reprod Update. 2023 May 2;29(3):327-346. doi: 10.1093/humupd/dmac045.
5
Correlation of oocyte number with serum anti-Müllerian hormone levels measured by either Access or Elecsys in fresh in vitro fertilization cycles.在新鲜体外受精周期中,通过Access或Elecsys检测的卵母细胞数量与血清抗苗勒管激素水平的相关性。
Clin Exp Reprod Med. 2022 Sep;49(3):202-209. doi: 10.5653/cerm.2022.05211. Epub 2022 Aug 31.